Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2026-03-05 @ 6:57 PM
Study NCT ID:
NCT02891603
Status:
COMPLETED
Last Update Posted:
2025-10-10
First Post:
2016-09-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization: